CurifyLabs, a Helsinki, Finland-based healthtech firm offering an answer to automate the manufacturing of compounded medication, raised €6.7M in funding.
The spherical was led by Springvest with participation from Enterprise Finland.
The corporate intends to us etch funds to scale its operations and safe high-volume clients available in the market.
Led by CEO Charlotta Topelius, CurifyLabs offers a compounding system answer (CSS), which is an automatic pharmaceutical compounding platform for non-sterile dosage kinds, together with tablets, troches, liquids, suppositories, vagitories, ointments, and capsules. It allows new remedies for sufferers and improved effectivity for pharmacies and hospital pharmacies.
CurifyLabs’ CSS know-how is at the moment in use for sufferers by clients in Europe and america.
FinSMEs
30/05/2025
